CA-RIMINI-STREET
1.9.2021 23:14:04 CEST | Business Wire | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced it has extended its award-winning, mission-critical, 24x7x365 support, application management, security and migration services beyond proprietary databases to leading open source database platforms, including MySQL, MariaDB, PostgreSQL and MongoDB.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210901006033/en/
Rimini Street has nearly 400 full-time database-skilled engineers and has already provided database services to more than 1,400 clients around the world who have relied on Rimini Street for mission-critical support with a guaranteed 10-minute engineer response time for P1 critical cases, 24x7x365, anywhere in the world for their database platforms – including support of proprietary and open source database platforms in data center and cloud environments. Clients served range from some of the largest and most complex Fortune 500 and Global 100 database infrastructures with thousands of instances across many countries to mid-size businesses with single database instances. Industries served range from manufacturing, distribution, energy, retail, hospitality, transportation, financial services, healthcare, public sector, military, defense sector, technology, media and telecom.
A Single Support Provider for a Diverse and Growing Enterprise Database Landscape
Rimini Street’s unified, vendor-independent database service simplifies operational management of increasingly diverse, complex and growing database environments across the enterprise, improving system performance, outcomes and user satisfaction, while also enabling clients to gain financial and resource efficiencies that free up IT resources – time, money and personnel – to focus on more strategic business priorities.
All clients have at least one assigned Primary Support Engineer – backed by a team of skilled database experts – who have an average of 20 years’ experience. Proprietary, patent-pending artificial intelligence tools are utilized to canvas the expertise of hundreds of Rimini Street support engineers to pinpoint resources for solving customer issues in seconds. The Company’s client satisfaction score with closed cases averages 4.9 out of 5.0 (where 5.0 is “excellent”).
Open Source Databases Surpass Proprietary Databases in Popularity
According to a 2021 ranking by DB-Engines, open source databases have now surpassed proprietary databases in popularity1 . There are many factors leading to the increase in popularity including license and support cost savings, avoiding license compliance issues and flexibility of deployment.
Rimini Street Fills Need for Enterprise-Class Open Source Database Services
While the open source database market is increasing in popularity it is also creating new challenges for CIO’s and their IT teams, specifically with the traditional open source support model which includes reliance on self-support, trial and error operational models and community support, which do not provide sufficient support for mission-critical operational requirements.
Self-support often means learn as you go, as database administrator skills are not readily transferable between different platforms. Open source community support lacks the rapid and reliable, 24/7/365 response IT departments’ need to resolve critical issues, as well as the depth of experience with enterprise applications for performance tuning, security, virtualization, system diagnostics and high availability requirements. Rimini Street’s services for open source databases addresses these challenges by delivering the level of support missing with self-support, community support and support from a vendor who may not have Rimini Street’s extensive and comprehensive enterprise-class engineering staff and global, 24x7x365 mission-critical “turnkey” delivery capability.
“Community and self-support options are not sufficient for IT departments who want to expand use of open source and also meet the service level requirements of their business,” said R ‘Ray’ Wang, principal analyst and founder, Constellation Research. “What is needed is an enterprise-class software support model that not only fills this need in the market, but also helps simplify management of the new and changing mix of proprietary and open source databases across the enterprise.”
Expert Migration from Proprietary to Open Source Databases
Complementing Rimini Street’s unified service for databases, the Company also offers migration advisory and full database migration services to help organizations smoothly and methodically diversify their database landscape to leverage open source platforms where possible to optimize cost and operational benefits. The Company’s broad database expertise helps clients design and execute a strategy to migrate selected missions and instances from proprietary to open source databases, providing service through the entire database migration journey from strategic planning, execution of the migration and go-live.
Innovative Application Management and Database Security Services
Rimini Street offers a comprehensive suite of application management and advanced database security services across proprietary and open source database platforms. Rimini Street’s application management services (AMS) include proactive database health checks and 24x7x365 mission-critical performance and operational monitoring that enables the Company’s engineers to identify and address potential issues before they impact systems and users. Rimini Street’s Advanced Database Security (ADS) service includes innovative, proven software and technology that can block identified attack vectors and vulnerabilities in hours – not the weeks, months and years and expensive testing that can be the case with the software vendor’s old and insufficient patching model.
“Clients have already engaged us to extend our ultra-responsive, award-winning support beyond their proprietary database environment to leading open source databases and have leveraged our database migration services,” said Seth A. Ravin , Rimini Street CEO. “Rimini Street is now enabling organizations to maximize the use and value of both proprietary and open source database platforms across their enterprise, all supported under a single application partner with a seamless, ultra-responsive service offering across all their database platforms. Our clients are benefiting from Rimini Street’s proven database expertise, deep engineer bench, breath of service scope and enterprise-class delivery capability.”
For more information on Rimini Street’s award-winning services for databases click here .
About Rimini Street, Inc.
Rimini Street, Inc. (Nasdaq: RMNI), a Russell 2000® Company, is a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner. The Company offers premium, ultra-responsive and integrated application management and support services that enable enterprise software licensees to save significant costs, free up resources for innovation and achieve better business outcomes. To date, more than 4,200 Fortune 500, Fortune Global 100, midmarket, public sector and other organizations from a broad range of industries have relied on Rimini Street as their trusted application enterprise software products and services provider. To learn more, please visit http://www.riministreet.com , follow @riministreet on Twitter and find Rimini Street on Facebook and LinkedIn .
Forward-Looking Statements
Certain statements included in this communication are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “may,” “should,” “would,” “plan,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “seem,” “seek,” “continue,” “future,” “will,” “expect,” “outlook” or other similar words, phrases or expressions. These forward-looking statements include, but are not limited to, statements regarding our expectations of future events, future opportunities, global expansion and other growth initiatives and our investments in such initiatives. These statements are based on various assumptions and on the current expectations of management and are not predictions of actual performance, nor are these statements of historical facts. These statements are subject to a number of risks and uncertainties regarding Rimini Street’s business, and actual results may differ materially. These risks and uncertainties include, but are not limited to, the impact of our credit facility’s ongoing debt service obligations and financial covenants and operational covenants on our business and related interest rate risk, the duration of and operational and financial impacts on our business of the COVID-19 pandemic and related economic impact, as well as the actions taken by governmental authorities, clients or others in response to the COVID-19 pandemic; catastrophic events that disrupt our business or that of our current and prospective clients, changes in the business environment in which Rimini Street operates, including inflation and interest rates, and general financial, economic, regulatory and political conditions affecting the industry in which Rimini Street operates; adverse developments in pending litigation or in the government inquiry or any new litigation; our need and ability to raise additional equity or debt financing on favorable terms and our ability to generate cash flows from operations to help fund increased investment in our growth initiatives; the sufficiency of our cash and cash equivalents to meet our liquidity requirements; including under our new credit facility; our ability to maintain an effective system of internal control over financial reporting, and our ability to remediate identified material weaknesses in our internal controls, including in relation to the accounting treatment of our warrants; changes in taxes, laws and regulations; competitive product and pricing activity; difficulties of managing growth profitably; the customer adoption of our recently introduced products and services, including our Application Management Services (AMS), Rimini Street Advanced Database Security, and services for Salesforce Sales Cloud and Service Cloud products, in addition to other products and services we expect to introduce in the near future; the loss of one or more members of Rimini Street’s management team; uncertainty as to the long-term value of Rimini Street’s equity securities; and those discussed under the heading “Risk Factors” in Rimini Street’s Quarterly Report on Form 10-Q filed on August 4, 2021, and as updated from time to time by Rimini Street’s future Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings by Rimini Street with the Securities and Exchange Commission. In addition, forward-looking statements provide Rimini Street’s expectations, plans or forecasts of future events and views as of the date of this communication. Rimini Street anticipates that subsequent events and developments will cause Rimini Street’s assessments to change. However, while Rimini Street may elect to update these forward-looking statements at some point in the future, Rimini Street specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Rimini Street’s assessments as of any date subsequent to the date of this communication.
© 2021 Rimini Street, Inc. All rights reserved. “Rimini Street” is a registered trademark of Rimini Street, Inc. in the United States and other countries, and Rimini Street, the Rimini Street logo, and combinations thereof, and other marks marked by TM are trademarks of Rimini Street, Inc. All other trademarks remain the property of their respective owners, and unless otherwise specified, Rimini Street claims no affiliation, endorsement, or association with any such trademark holder or other companies referenced herein.
______________________________________________
1 DB-Engines, Open Source vs. Commercial databases, https://db-engines.com/en/ranking_osvsc
View source version on businesswire.com: https://www.businesswire.com/news/home/20210901006033/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders8.7.2026 15:00:00 CEST | Press release
Trial reports correlations between ketone levels and cognitive and psychiatric symptoms in individuals with schizophrenia-spectrum and bipolar-1 disorders Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar-1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month RCT open-label phase. Furthermore, those who continued with the optional four-month single-arm ketogenic diet extension saw meaningful gains across metabolic, psychiatric, and cognitive measures. This press release features multimedia. View the full release here: https://www.businesswire.co
Teamily AI Publicly Launches Human+AI Social Platform to Make Building and Growing a Company Easy for Every Team8.7.2026 15:00:00 CEST | Press release
Teamily AI (https://Teamily.ai), together with its Agentic AI Infra platform TensorOpera AI (https://TensorOpera.ai), today announced the public launch of its Human+AI social platform, a product stack that has already served more than 5 million users around the world. Starting today in Palo Alto and rolling out simultaneously across dozens of countries, this first public launch opens the full stack to everyone with a single mission: to make building and growing a company easy for every person and every team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708584390/en/ "This is the moment we open our doors to the world," said co-founders Dr. Aiden Chaoyang He and Professor Salman Avestimehr. "We want every person and every team to be able to move from idea to product, from product to market, and from market to growth and investment, with an AI-native team by their side." At its core, Teamily AI enables humans and AI agents
Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press release
Oversubscribed round follows the world-first compact upright proton treatment at Stanford Medicine — funding a single upright platform that will span imaging and treatment across multiple radiation modalities. Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and
LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press release
The Halocene H4 quantum computer, named LUMI-IQ, will be delivered and installed in 2027 The system will be hosted at CSC – IT Center for Science in Finland and integrated into the LUMI AI Factory The system will provide researchers, industry innovators, and developers across Europe with a unique, advanced experimental platform where quantum computing and artificial intelligence converge The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer o
Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations8.7.2026 14:00:00 CEST | Press release
Enpatoran could address a significant unmet need in lupus, specifically targeting cutaneous manifestations of the disease, which currently have no approved therapiesFDA's decision was supported by Phase 2 WILLOW study results, which demonstrated meaningful symptoms improvement, particularly among patients with active cutaneous manifestationsEnpatoran's potential to go beyond current treatment standards in lupus prompted FDA´s breakthrough designation, which is designed to expedite drug development and reviewNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enpatoran for the treatment of lupus with active cutaneous manifestations. Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor, designed to modulate pathways central to lupus-related inflammation. “For the 85% of lupus patients whose disease includes skin manif
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
